1 results match your criteria: "Kagoshima University and Kagoshima University Hospital Kagoshima[Affiliation]"
One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient.
J Cachexia Sarcopenia Muscle
September 2015
Department of Psychosomatic Internal Medicine, Graduate School of Medical and Dental Sciences, Kagoshima University and Kagoshima University Hospital Kagoshima, 890-8520, Japan.
Background: In Japan, growth hormone releasing peptide-2 (GHRP-2) is clinically used as a diagnostic agent for growth hormone secretion deficiency, but the therapeutic application of GHRP-2 has not been studied in anorexia nervosa. GHRP-2 reportedly exhibits agonistic action for ghrelin receptor and increases food intake.
Methods: We administered GHRP-2 to a patient with a 20-year history of anorexia nervosa to determine whether GHRP-2 treatment increases food intake and body weight.